Robinson Value Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Robinson Value Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,452	Closed	-$1.33M	–	80
2024 Q3	$1.33M	Buy	13,452 +155	+1%	+$15.2K	0.86%	44
2024 Q2	$1.23M	Sell	13,297 -373	-3%	-$33.4K	0.86%	41
2024 Q1	$1.3M	Buy	+13,670	New	+$1.27M	0.87%	40
2023 Q1	–	Sell	-7,963	Closed	-$661K	–	75
2022 Q4	$661K	Buy	+7,963	New	+$645K	0.57%	43
2021 Q1	–	Sell	-2,401	Closed	-$338K	–	68
2020 Q4	$338K	Buy	+2,401	New	+$308K	0.32%	52
2018 Q3	$366K	Sell	3,819 -1,045	-21%	-$101K	0.34%	53
2018 Q2	$463K	Buy	+4,864	New	+$447K	0.42%	46

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Robinson Value Management's XBI Position: Q4 2024 in Review

Robinson Value Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 13,452 shares — an estimated $1.33M sold.

Robinson Value Management first reported a position in XBI in Q2 2018 and held it in 7 quarters. The position peaked at $1.33M in Q3 2024. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

Robinson Value Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
Robinson Value Management sold 13,452 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $1.33M.
Robinson Value Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and held it in 7 quarters.
Robinson Value Management's State Street SPDR S&P Biotech ETF position peaked at $1.33M in Q3 2024.
738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Robinson Value Management's 13F filing for Q4 2024, filed 28 Jan 2025.